4.6 Article

Serum vitamin levels in multiple system atrophy: A case-control study

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

An umbrella review of systematic reviews with meta-analysis on the role of vitamins in Parkinson's disease

Sama Rahnemayan et al.

Summary: This umbrella review systematically reviewed the literature on the association between dietary intake or serum levels of different vitamins and the risk of PD. It found that PD patients had significantly lower levels of serum vitamin D and B12, and higher levels of homocysteine. Higher vitamin E intake was associated with significantly lower risk of PD development. However, there was no significant difference in the risk of PD and higher intake or serum levels of vitamin A, C, B6, or folate.

ACTA NEUROLOGICA BELGICA (2023)

Article Clinical Neurology

Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study

Min Zhong et al.

Summary: This study found a higher plasma homocysteine concentration in patients with minor hallucinations in Parkinson's disease, and revealed that homocysteine is associated with certain symptoms in patients with minor hallucinations.

BEHAVIOURAL NEUROLOGY (2022)

Article Geriatrics & Gerontology

A Metabolomic Aging Clock Using Human Cerebrospinal Fluid

Nathan Hwangbo et al.

Summary: Quantifying the physiology of aging is crucial for understanding age-related diseases and healthy aging heterogeneity. Recent studies indicate that omic clocks provide measures of biological age, with metabolomic profiles able to predict chronological age within 10 years in healthy subjects. Predictive models for age using metabolomic profiles show increased prediction error in subjects with Alzheimer's and Parkinson's disease, possibly indicating differences in the relationship between the metabolome and chronological age in these diseases.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2022)

Article Biochemistry & Molecular Biology

Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid

Nathan Hwangbo et al.

Summary: Metabolomics has been utilized to analyze human cerebrospinal fluid samples and found strong separation between PD and AD patients and healthy controls in the metabolome. Key metabolites associated with PD and AD classification were identified, along with metabolic pathways linked to these neurodegenerative diseases.

METABOLITES (2022)

Article Medicine, General & Internal

Multiple system atrophy

Werner Poewe et al.

Summary: This article provides a summary of the epidemiology, diagnosis, pathophysiology, and treatment of multiple system atrophy, as well as an overview of quality of life issues and future research directions. Multiple system atrophy is a rare neurodegenerative disease characterized by neuronal loss and gliosis in multiple areas of the central nervous system. Diagnosis is challenging and current treatments are not effective, but new research progress offers hope for patients.

NATURE REVIEWS DISEASE PRIMERS (2022)

Review Neurosciences

Neuropathology and molecular diagnosis of Synucleinopathies

Shunsuke Koga et al.

Summary: Synucleinopathies are a group of diseases characterized by pathological aggregates of alpha-synuclein in neurons and glia. The two main disease entities are Lewy body disease and multiple system atrophy, each with different clinical subtypes. Currently, there are no disease-modifying therapies, but research on molecular mechanisms provides hope for future treatments.

MOLECULAR NEURODEGENERATION (2021)

Review Clinical Neurology

Gastrointestinal dysfunction in movement disorders

Ryuji Sakakibara

Summary: This article provides an overview of gastrointestinal tract dysfunction in patients with Parkinson's disease and other movement disorders, including clinical presentation, investigations, and treatment options. Bowel dysfunction is common in these patients and may present as constipation, fecal incontinence, and GI emergencies such as intestinal pseudo-obstruction and volvulus. Management options include bulking agents, softening agents, probiotics, and specialized procedures like botulinum toxin injections.

NEUROLOGICAL SCIENCES (2021)

Article Public, Environmental & Occupational Health

The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's Disease in the Northwest of Iran

Haleh BARMAKI et al.

Iranian Journal of Public Health (2021)

Article Cell Biology

Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease

Dorines Rosario et al.

Summary: Parkinson's disease (PD) is a common progressive neurological disorder that affects motor functions, with gastrointestinal (GI) dysfunction being an early nonmotor symptom. This study used metagenomics and serum metabolomics to investigate the gut microbiome of PD patients. The findings suggest that gut microbial composition and metabolism may play a role in PD pathophysiology.

CELL REPORTS (2021)

Article Geriatrics & Gerontology

Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer ? s disease

Imrich Blasko et al.

Summary: This study investigated the effectiveness of lipid metabolites and vitamin B12 and folate levels as biomarkers for predicting MCI-to-AD conversion. The findings suggest that some plasma lipids significantly change in subjects converting to AD, while folate levels decrease in MCI-AD conversion. Further research is needed to determine if peripheral lipid changes correspond with brain changes during the course of the disease, indicating potential for lipids as prognostic markers.

EXPERIMENTAL GERONTOLOGY (2021)

Article Clinical Neurology

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders

Isabel Schulz et al.

Summary: Objective diagnostic biomarkers are needed to support a clinical diagnosis of neurodegenerative disorders, with various markers being analyzed in serum and/or cerebrospinal fluid for alpha-synuclein-related disorders. Levels of most markers tested significantly differed between disease groups and healthy controls, with CSF NfL levels best discriminating between Parkinson's disease and multiple system atrophy.

MOVEMENT DISORDERS (2021)

Review Nutrition & Dietetics

Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review

Jikke T. Boelens Keun et al.

Summary: This systematic review found that nutritional interventions to optimize levodopa therapy in Parkinson's Disease patients, including protein redistribution diets, dietary fiber, vitamin C, and caffeine, can improve levodopa absorption and reduce motor fluctuations. Additionally, supplementation of vitamin B-12, vitamin B-6, and folic acid can lower high homocysteine levels and alleviate metabolic and clinical complications associated with levodopa therapy.

ADVANCES IN NUTRITION (2021)

Article Clinical Neurology

Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study

Siying Li et al.

Summary: This study found that serum folate, vitamin B12 levels, and Systemic Immune-Inflammation Index significantly influence the motor performance status in patients with Parkinson's disease, with elevated folate levels correlating with mild motor impairment.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis

Bao Dong et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2020)

Article Clinical Neurology

Lower Vitamin B12 Level at Multiple System Atrophy Diagnosis Is Associated With Shorter Survival

Stuart J. McCarter et al.

MOVEMENT DISORDERS (2020)

Article Clinical Neurology

Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression

Chadwick W. Christine et al.

MOVEMENT DISORDERS (2020)

Article Neurosciences

Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study

Alexandra Foubert-Samier et al.

NEUROBIOLOGY OF DISEASE (2020)

Review Biochemistry & Molecular Biology

Retinoic acid receptor-targeted drugs in neurodegenerative disease

Jason Nicol Clark et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)

Article Clinical Neurology

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence

Tommaso Schirinzi et al.

FRONTIERS IN NEUROLOGY (2019)

Article Clinical Neurology

A critique of the second consensus criteria for multiple system atrophy

Iva Stankovic et al.

MOVEMENT DISORDERS (2019)

Article Neurosciences

Alterations of the Gut Microbiota in Multiple System Atrophy Patients

Linlin Wan et al.

FRONTIERS IN NEUROSCIENCE (2019)

Letter Clinical Neurology

Altered Gut Microbiome and Metabolome in Patients With Multiple System Atrophy

Elahe Elahi

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease

Chadwick W. Christine et al.

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia

Fati Nourhashemi et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Review Clinical Neurology

Multiple system atrophy: insights into a rare and debilitating movement disorder

Florian Krismer et al.

NATURE REVIEWS NEUROLOGY (2017)

Article Biochemistry & Molecular Biology

Folic Acid Protected Neural Cells Against Aluminum-Maltolate-Induced Apoptosis by Preventing miR-19 Downregulation

Mingming Zhu et al.

NEUROCHEMICAL RESEARCH (2016)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Review Medicine, General & Internal

Multiple-System Atrophy

Alessandra Fanciulli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Nutrition & Dietetics

Associations between B Vitamins and Parkinson's Disease

Liang Shen

NUTRIENTS (2015)

Article Biochemistry & Molecular Biology

(Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy

Diana Macedo et al.

HUMAN MOLECULAR GENETICS (2015)

Article Clinical Neurology

The natural history of multiple system atrophy: a prospective European cohort study

Gregor K. Wenning et al.

LANCET NEUROLOGY (2013)

Article Neurosciences

Memory, Mood, and Vitamin D in Persons with Parkinson's Disease

Amie L. Peterson et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Review Clinical Neurology

The neuropathology, pathophysiology and genetics of multiple system atrophy

Z. Ahmed et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)

Article Clinical Neurology

Assessment of the Scopa-Aut questionnaire in multiple system atrophy: Relation to UMSARS scores and progression over time

Nathalie Damon-Perriere et al.

PARKINSONISM & RELATED DISORDERS (2012)

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

Article Clinical Neurology

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

GK Wenning et al.

MOVEMENT DISORDERS (2004)

Article Medicine, General & Internal

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

S Seshadri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)